Skip to main content

Reporter

AAMC meet highlights need for research funds

Sep. 27, 2012—During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research.

Read more


Biostatistics Clinics help investigators hone studies

Sep. 27, 2012—Amory Cox, a Pharmacy Practice resident, is making her second visit to the Biostatistics Clinic, a free, 75- minute research help session offered daily by the Department of Biostatistics.

Read more


Target acquired for aggressive tumor

Sep. 27, 2012—New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.

Read more


LifeFlight goes pink for breast cancer awareness

Sep. 26, 2012—Vanderbilt LifeFlight is going pink during October to show its support for breast cancer awareness. LifeFlight medical crews will wear a special pink name badge on their flight suits and other staff will wear pink golf shirts.

Read more


Cell entry ports for cold virus

Sep. 25, 2012—The respiratory virus HMPV uses its fusion (F) protein – which interacts with cellular receptors called integrins – to bind to and enter target cells.

Read more


Little evidence supports medical treatment options for adolescents with autism

Sep. 24, 2012—Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population.

Read more


VU, Bristol-Myers to collaborate on Parkinson’s therapies

Sep. 21, 2012—Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.

Read more


HER2 may impact lung cancer therapy

Sep. 21, 2012—A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.

Read more


Wellons named chief of Pediatric Neurosurgery

Sep. 20, 2012—The Department of Neurological Surgery has recruited John “Jay” Wellons III, M.D., MSPH, to serve as chief of Pediatric Neurosurgery.

Read more


Mchaourab to lead Chemical and Physical Biology program

Sep. 20, 2012—Hassane Mchaourab, Ph.D., professor of Molecular Physiology & Biophysics, Physics and Chemistry, has been named the new director of the Ph.D.-granting Chemical and Physical Biology (CPB) program at Vanderbilt University.

Read more


Cancer Wellness Program launches ‘Thrivership’ classes

Sep. 20, 2012—Adult cancer patients and survivors are invited to participate in Vanderbilt-Ingram Cancer Center’s new Thrivership Program, which is designed to restore wellness through physical activity, enhanced nutrition, body awareness and emotional well-being.

Read more


Schaffner lauded for epidemiology contributions

Sep. 20, 2012—William Schaffner, M.D., professor and chair of Preventive Medicine, is the 2012 recipient of the American College of Epidemiology’s Abraham Lilienfeld Award, in recognition of his contributions and leadership in the discipline of epidemiology.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more